New incident report
Incident Report Number: 2012-5401
Registrant Reference Number: 4919225
Registrant Name (Full Legal Name no abbreviations): Sure-Gro Inc.
Address: 150 Savannah Oaks Dr.
City: Brantford
Prov / State: Ontario
Country: Canada
Postal Code: N3V 1E7
Domestic Animal
Country: CANADA
Prov / State: BRITISH COLUMBIA
PMRA Registration No. 27587 PMRA Submission No. EPA Registration No.
Product Name: CIL Jet Foam Wasp and Hornet Killer
Yes
Unknown
Site: Unknown / Inconnu
Unknown
Animal's Owner
Dog / Chien
Miniature Schnauzer
1
Female
9
25
lbs
Oral
>15 min <=2 hrs / >15 min <=2 h
>8 hrs <=24 hrs / > 8 h < = 24 h
System
Unknown / Inconnu
Unknown
Unknown
Unknown/Inconnu
Accidental ingestion/Ingestion accident.
(eg. description of the frequency and severity of the symptoms
Pet owner calling because her pet ingested part of a Wasp nest approx 30 mins after being sprayed. Pet owner stated that the pet was asymptomatic until 4:00 CST yesterday when the pet became agitated, ataxic, and very lethargic. The Caller was advised that the insecticides in this product have a wide margin of safety in dogs. Significant systemic effects are not expected. Could see mild anorexia, vomiting and or diarrhea from this exposure. Pet owner should take the pet to the rDVM. Later on that day the Owner called back as her DVM who does house calls is at her home. Discussed the case with the DVM. The DVM reports the dog has a pre-exisiting fungal infection of the brain. Advised DVM that from this type of exposure we would not expect significant signs. Could see mild anorexia and or vomiting. Suspect the signs are related to the dog's pre-existing condition.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified.